STANFORD UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1885-11-11
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.stanford.edu
A Brief Behavioral Sleep Intervention for Depression Among Military Veterans
Not Applicable
Completed
- Conditions
- InsomniaSuicidal IdeationDepression
- Interventions
- Behavioral: Sleep Intervention IBehavioral: Sleep Intervention II
- First Posted Date
- 2013-10-09
- Last Posted Date
- 2018-04-26
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 77
- Registration Number
- NCT01958541
- Locations
- 🇺🇸
VA Palo Alto Healthcare System, Palo Alto, California, United States
🇺🇸Stanford University, Stanford, California, United States
Prevention Trial Assessing Paper-Tape in Endurance Distances II (Pre-TAPED II)
Not Applicable
Completed
- Conditions
- Blister of Foot
- Interventions
- Device: Paper Tape
- First Posted Date
- 2013-09-18
- Last Posted Date
- 2018-12-12
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 128
- Registration Number
- NCT01945112
- Locations
- 🇺🇸
Stanford University, Stanford, California, United States
Stereotactic Body Radiation Therapy and T-Cell Infusion in Treating Patients With Metastatic Kidney Cancer
Phase 1
Terminated
- Conditions
- Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
- Interventions
- Radiation: stereotactic body radiation therapyDrug: cyclophosphamideBiological: therapeutic autologous lymphocytesOther: laboratory biomarker analysis
- First Posted Date
- 2013-09-16
- Last Posted Date
- 2017-03-15
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 2
- Registration Number
- NCT01943188
- Locations
- 🇺🇸
Stanford University Hospitals and Clinics, Stanford, California, United States
Improving Self Management Skills of Older Adults With Diabetes
Not Applicable
Completed
- Conditions
- DiabetesType 2 Diabetes
- Interventions
- Behavioral: Diabetes Self Management Program
- First Posted Date
- 2013-09-16
- Last Posted Date
- 2017-04-25
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 1000
- Registration Number
- NCT01943357
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
Oxytocin Infusions and Blood Loss in Patients Undergoing Elective Cesarean Delivery.
- First Posted Date
- 2013-08-30
- Last Posted Date
- 2017-02-01
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 51
- Registration Number
- NCT01932060
- Locations
- 🇺🇸
Lucile Packard Children's Hospital, Stanford University, Stanford, California, United States
Recombinant Human Hyaluronidase in Treating Lymphedema in Patients With Cancer
Phase 1
Terminated
- Conditions
- LymphedemaMalignant Neoplasm
- Interventions
- Biological: recombinant human hyaluronidase
- First Posted Date
- 2013-08-23
- Last Posted Date
- 2017-03-21
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 3
- Registration Number
- NCT01928030
- Locations
- 🇺🇸
Stanford University Hospitals and Clinics, Stanford, California, United States
The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.
Phase 4
Withdrawn
- Conditions
- GlaucomaOcular HypertensionThyroid Eye Disease
- Interventions
- Drug: Prostaglandin AnalogDrug: Timolol
- First Posted Date
- 2013-08-22
- Last Posted Date
- 2018-05-15
- Lead Sponsor
- Stanford University
- Registration Number
- NCT01927406
- Locations
- 🇺🇸
Stanford Hospital and Clinics, Stanford, California, United States
Perfusion CT Monitoring to Predict Treatment Efficacy in Renal Cell Carcinoma
Completed
- Conditions
- Metastatic Renal Cell Cancer
- First Posted Date
- 2013-08-21
- Last Posted Date
- 2022-02-02
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 19
- Registration Number
- NCT01926990
- Locations
- 🇺🇸
Stanford University Cancer Institute, Stanford, California, United States
Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer
Phase 3
Completed
- Conditions
- Pancreatic Cancer
- Interventions
- Drug: OxaliplatinDrug: IrinotecanDrug: LeucovorinDrug: 5FURadiation: Stereotactic Body Radiotherapy (SBRT)
- First Posted Date
- 2013-08-20
- Last Posted Date
- 2022-10-28
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 27
- Registration Number
- NCT01926197
- Locations
- 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
🇺🇸Loyola University, Maywood, Illinois, United States
🇺🇸Swedish Cancer Institute, Seattle, Washington, United States
TMS for CRPS - Pilot Study
Not Applicable
Completed
- Conditions
- Complex Regional Pain Syndrome (CRPS)
- Interventions
- Device: Transcranial Magnetic Stimulation
- First Posted Date
- 2013-08-20
- Last Posted Date
- 2017-05-10
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 4
- Registration Number
- NCT01926119
- Locations
- 🇺🇸
Stanford University School of Medicine, Palo Alto, California, United States
© Copyright 2025. All Rights Reserved by MedPath